Einträge von Harrer, Dennis C. auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 6.
2025
Hansmann, Helena, Henkel, Chiara, Fante, Matthias A. 
, Harrer, Dennis C. , Heidemanns, Stefanie , Oellerich, Michael, Beck, Julia, Schütz, Ekkehard, Biswenger, Verena, Perl, Markus, Zartner, Barbara, Edinger, Matthias , Wolff, Daniel , Hoffmann, Petra, Herr, Wolfgang, Banas, Bernhard , Zecher, Daniel und Hansmann, Leo
(2025)
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder.
American Journal of Transplantation 26 (2), S. 340-348.
2024
Perl, Markus, Herfeld, Konstantin, Harrer, Dennis C. , Höpting, Matthias, Schweiger, Marina, Sterz, Ulrich, Knödler, Leonard, Heimerl, Susanne, Hansmann, Leo , Herr, Wolfgang, Poeck, Hendrik, Wolff, Daniel , Edinger, Matthias, Hart, Christina und Fante, Matthias Alexander
(2024)
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.
Haematologica.
2023
Fante, Matthias A., Harrer, Dennis C., Zartner, Barbara, Lüke, Florian, Mayer, Stephanie, Menhart, Karin, Reichle, Albrecht , Herr, Wolfgang, Vogelhuber, Martin und Heudobler, Daniel
(2023)
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.
Frontiers in Oncology 13.
2022
Harrer, Dennis C., Jakob, Marcus, Vogelhuber, Martin, Lüke, Florian, Utpatel, Kirsten, Corbacioglu, Selim, Herr, Wolfgang, Reichle, Albrecht und Heudobler, Daniel
(2022)
Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis.
Leukemia & Lymphoma 63 (12), S. 2858-2868.
Volltext nicht vorhanden.
2021
Lüke, Florian, Harrer, Dennis C., Menhart, Karin, Wolff, Daniel, Holler, Ernst, Hellwig, Dirk, Herr, Wolfgang, Grube, Matthias, Vogelhuber, Martin, Reichle, Albrecht und Heudobler, Daniel
(2021)
Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease.
Frontiers in Pharmacology 12 (599561), S. 1-8.
Lüke, Florian, Harrer, Dennis C., Hahn, Joachim, Grube, Matthias, Pukrop, Tobias, Herr, Wolfgang, Reichle, Albrecht und Heudobler, Daniel
(2021)
Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Frontiers in Pharmacology 2021 (12), S. 599552.